{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:06:45Z","timestamp":1790744805060,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008081","name":"Dystrophic Epidermolysis Bullosa Research Association","doi-asserted-by":"publisher","award":["APR-2020-008"],"award-info":[{"award-number":["APR-2020-008"]}],"id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011960","name":"DEBRA International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2010-AdG"],"award-info":[{"award-number":["ERC-2010-AdG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jid.2023.10.035","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T17:00:00Z","timestamp":1701450000000},"page":"1322-1333.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Highly Efficient Ex\u00a0Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR\/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8769-3458","authenticated-orcid":false,"given":"Camille","family":"Berthault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-3239","authenticated-orcid":false,"given":"Sonia","family":"Gaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2649-5844","authenticated-orcid":false,"given":"Olivier","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-2277","authenticated-orcid":false,"given":"Alain","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-147X","authenticated-orcid":false,"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-7120","authenticated-orcid":false,"given":"David","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-2769","authenticated-orcid":false,"given":"Matthias","family":"Titeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-7512","authenticated-orcid":false,"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6358-6980","authenticated-orcid":false,"given":"Araksya","family":"Izmiryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.10.035_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","article-title":"Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing","volume":"29","author":"Bonafont","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.10.035_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR\/Cas9-mediated gene editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.10.035_bib3","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3390\/ijms24032298","article-title":"Challenges of gene editing therapies for genodermatoses","volume":"24","author":"Brooks","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.10.035_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jid.2023.10.035_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2005.06542.x","article-title":"High frequency of the 425A>G splice-site mutation and novel mutations of the COL7A1 gene in central Europe: significance for future mutation detection strategies in dystrophic epidermolysis bullosa","volume":"152","author":"Csik\u00f3s","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.10.035_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Esc\u00e1mez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.10.035_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.10.035_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.10.035_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.omtm.2022.09.005","article-title":"Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in\u00a0vivo CRISPR-Cas9 delivery using adenoviral vectors","volume":"27","author":"Garc\u00eda","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jid.2023.10.035_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","article-title":"Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development","volume":"63","author":"Guerra","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2023.10.035_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In\u00a0vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.10.035_bib42","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.10.035_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.10.035_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2023.10.035_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.10.035_bib15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2018.06.008","article-title":"Ex\u00a0vivo COL7A1 correction for recessive dystrophic epidermolysis bullosa using CRISPR\/Cas9 and homology-directed repair","volume":"12","author":"Izmiryan","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jid.2023.10.035_bib16","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1073\/pnas.1907081116","article-title":"CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells","volume":"116","author":"Jackow","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.10.035_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"ELife"},{"key":"10.1016\/j.jid.2023.10.035_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.10.035_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtn.2021.05.015","article-title":"A\u00a0non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa","volume":"25","author":"Kocher","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jid.2023.10.035_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41467-018-03190-3","article-title":"High-efficiency RNA-based reprogramming of human primary fibroblasts","volume":"9","author":"Kogut","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.10.035_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.10.035_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cells9010112","article-title":"Context-dependent strategies for enhanced genome editing of genodermatoses","volume":"9","author":"March","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jid.2023.10.035_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100191","article-title":"Cytosine deaminase base editing to restore COL7A1 in dystrophic epidermolysis bullosa human: murine skin model","volume":"3","author":"Naso","year":"2023","journal-title":"JID Innov"},{"key":"10.1016\/j.jid.2023.10.035_bib23","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1038\/s41598-019-41121-4","article-title":"Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs","volume":"9","author":"Okamoto","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.10.035_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jid.2019.07.701","article-title":"Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs","volume":"140","author":"Osborn","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.10.035_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0092-8674(94)90383-2","article-title":"Location of stem cells of human hair follicles by clonal analysis","volume":"76","author":"Rochat","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.10.035_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa2215643","article-title":"CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease","volume":"389","author":"Sharma","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.10.035_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24184-8","article-title":"ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation","volume":"12","author":"Sheriff","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.10.035_bib28","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2023.10.035_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jid.2023.10.035_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14728214.2020.1839049","article-title":"Emerging drugs for the treatment of epidermolysis bullosa","volume":"25","author":"Titeux","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jid.2023.10.035_bib31","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex\u00a0vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2023.10.035_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in\u00a0vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2023.10.035_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2023.10.035_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2023.10.035_bib35","first-page":"57","article-title":"Molecular pathology of the basement membrane zone in heritable blistering diseases:: the paradigm of epidermolysis bullosa","author":"Uitto","year":"2017","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2023.10.035_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A\u00a0high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2023.10.035_bib37","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/ajmg.a.62456","article-title":"Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest Sephardic ancestry","volume":"185","author":"Warshauer","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jid.2023.10.035_bib38","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2023.10.035_bib39","doi-asserted-by":"crossref","first-page":"14516","DOI":"10.1074\/jbc.272.23.14516","article-title":"Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin","volume":"272","author":"Chen","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2023.10.035_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0092-8674(94)90383-2","article-title":"Location of stem cells of human hair follicles by clonal analysis","volume":"76","author":"Rochat","year":"1994","journal-title":"Cell"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23031172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23031172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:10:57Z","timestamp":1728922257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23031172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022202X23031172"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.10.035","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly Efficient Ex\u00a0Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR\/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}